Bloomberg Businessweek cover image

Targeting the Toughest Diseases (Sponsored Content)

Bloomberg Businessweek

00:00

Targeting APOL1-Mediated Kidney Disease: Transformative Research and Raising Awareness

An exploration of Vertex Pharmaceuticals' groundbreaking research on APOL1-mediated kidney disease, including their efforts to develop transformative therapies and raise awareness for the devastating condition.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app